Showing results 1 to 8 of 8
Title | Author(s) | Issue Date | |
---|---|---|---|
Androgen Receptor as an Emerging Feasible Biomarker for Breast Cancer Journal:Biomolecules | 2022 | ||
Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer Journal:International Journal of Molecular Sciences | 2022 | ||
2020 | |||
M2-polarized macrophages induced invadopodia formation in EBV-associated nasopharyngeal carcinoma through TNFα signalling and LMP1 induction Proceeding/Conference:Research Postgraduate Symposium | 2017 | ||
Modulating the Activity of Androgen Receptor for Treating Breast Cancer Journal:International Journal of Molecular Sciences | 2022 | ||
2019 | |||
2022 | |||
Therapeutic evaluation of palbociclib and its compatibility with other chemotherapies for primary and recurrent nasopharyngeal carcinoma Journal:Journal of Experimental and Clinical Cancer Research | 2020 |